Evidence map›Paper›PMID 24210820›Full record

ArticleCell reports2013

SIRT7 represses Myc activity to suppress ER stress and prevent fatty liver disease.

Jiyung Shin, Ming He, Yufei Liu, Silvana Paredes, Lidia Villanova, Katharine Brown, Xiaolei Qiu, Noushin Nabavi, Mary Mohrin, Kathleen Wojnoonski and 12 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Cell reports, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 170 papers.

0numbers the graph read from it
0cells of the map it votes in
170citing papers in PubMed
10.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

170 citing papers in PubMed, 278 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

110 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

22 authors at 6 institutions in 3 countries.

Jiyung Shin *Program in Metabolic Biology, Nutritional Sciences & Toxicology, University of California, Berkeley, CA 94720, USA.
Ming He *Program in Metabolic Biology, Nutritional Sciences & Toxicology, University of California, Berkeley, CA 94720, USA.
Yufei Liu *Department of Molecular & Cell Biology, University of California, Berkeley, CA 94720, USA.
Silvana Paredes *Department of Medicine, Division of Endocrinology, Gerontology, and Metabolism, Stanford University School of Medicine, Stanford, CA 94305, USA.
Lidia VillanovaDepartment of Medicine, Division of Endocrinology, Gerontology, and Metabolism, Stanford University School of Medicine, Stanford, CA 94305, USA.
Katharine BrownProgram in Metabolic Biology, Nutritional Sciences & Toxicology, University of California, Berkeley, CA 94720, USA.
Xiaolei QiuProgram in Metabolic Biology, Nutritional Sciences & Toxicology, University of California, Berkeley, CA 94720, USA.
Noushin NabaviProgram in Metabolic Biology, Nutritional Sciences & Toxicology, University of California, Berkeley, CA 94720, USA.
Mary MohrinProgram in Metabolic Biology, Nutritional Sciences & Toxicology, University of California, Berkeley, CA 94720, USA.
Kathleen WojnoonskiDepartment of Atherosclerosis Research, Children's Hospital Oakland Research Institute, Oakland, CA 94609, USA.
Patrick LiBuck Institute for Research on Aging, 8001 Redwood Boulevard, Novato, CA 94945, USA.
Hwei-Ling ChengHoward Hughes Medical Institute, The Children's Hospital, CBR Institute for Biomedical Research, Harvard University Medical School, Boston, MA 02115, USA.
Andrew J MurphyRegeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, NY 10591, USA.
David M ValenzuelaRegeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, NY 10591, USA.
Hanzhi LuoProgram in Metabolic Biology, Nutritional Sciences & Toxicology, University of California, Berkeley, CA 94720, USA.
Pankaj KapahiBuck Institute for Research on Aging, 8001 Redwood Boulevard, Novato, CA 94945, USA.
Ronald KraussDepartment of Atherosclerosis Research, Children's Hospital Oakland Research Institute, Oakland, CA 94609, USA.
Raul MostoslavskyThe Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA.
George D YancopoulosRegeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, NY 10591, USA.
Frederick W AltHoward Hughes Medical Institute, The Children's Hospital, CBR Institute for Biomedical Research, Harvard University Medical School, Boston, MA 02115, USA.
Katrin F ChuaDepartment of Medicine, Division of Endocrinology, Gerontology, and Metabolism, Stanford University School of Medicine, Stanford, CA 94305, USA.
Danica ChenProgram in Metabolic Biology, Nutritional Sciences & Toxicology, University of California, Berkeley, CA 94720, USA.
University of California, Berkeley · USHarvard University · USRegeneron (United States) · USBuck Institute for Research on Aging · USVA Palo Alto Health Care System · USStanford University · US

Funding

Training in Basic Research on Aging and Age-Related DiseaseT32AG000266 · NIA · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI Lisa M Ellerby · 1998 to 2026
$13.8M
Diabetes, Endocrinology and Metabolism Training GrantT32DK007217 · NIDDK · STANFORD UNIVERSITY · PI Justin Pierce Annes, David Matthew Maahs · 1987 to 2026
$7.2M
Molecular Mechanisms of Lifespan Extension by Dietary Restriction in DrosophilaR01AG038688 · NIA · BUCK INSTITUTE FOR RESEARCH ON AGING · PI KAPAHI, PANKAJ · 2011 to 2015
$2.3M
Molecular Mechanisms of Mammalian SIRT6 FunctionR01AG028867 · NIA · STANFORD UNIVERSITY · PI CHUA, KATRIN F · 2006 to 2010
$1.6M
Nutrient Sensing and the Oxidative Stress ResponseR01AG040990 · NIA · UNIVERSITY OF CALIFORNIA BERKELEY · PI CHEN, DANICA · 2011 to 2015
$1.5M
Elucidating functions of mammalian SIRT7 deacetylase in aging and diseaseI01BX000286 · VA · VETERANS ADMIN PALO ALTO HEALTH CARE SYS · PI Katrin F. Chua · 2009 to 2026
–
BLRD VA I01 BX000286Howard Hughes Medical InstituteNIA NIH HHS R01 AG028867NIA NIH HHS R01AG028867NIA NIH HHS R01 AG038688NIA NIH HHS R01 AG040990NIA NIH HHS R01AG040990NIA NIH HHS T32 AG000266NIDDK NIH HHS 3T32DK007217-36S1NIDDK NIH HHS T32 DK007217
6 · The paper itself

Abstract

Nonalcoholic fatty liver disease is the most common chronic liver disorder in developed countries. Its pathogenesis is poorly understood, and therapeutic options are limited. Here, we show that SIRT7, an NAD(+)-dependent H3K18Ac deacetylase, functions at chromatin to suppress ER stress and prevent the development of fatty liver disease. SIRT7 is induced upon ER stress and is stabilized at the promoters of ribosomal proteins through its interaction with the transcription factor Myc to silence gene expression and to relieve ER stress. SIRT7-deficient mice develop chronic hepatosteatosis resembling human fatty liver disease. Myc inactivation or pharmacological suppression of ER stress alleviates fatty liver caused by SIRT7 deficiency. Importantly, SIRT7 suppresses ER stress and reverts the fatty liver disease in diet-induced obese mice. Our study identifies SIRT7 as a cofactor of Myc for transcriptional repression and delineates a druggable regulatory branch of the ER stress response that prevents and reverts fatty liver disease.

Indexed as

AnimalsEndoplasmic Reticulum StressFatty LiverFemaleGenes, mycHEK293 CellsHep G2 CellsHumansMaleMiceMice, Inbred C57BLMice, KnockoutNon-alcoholic Fatty Liver DiseaseProto-Oncogene Proteins c-mycSirtuinsTransfectionProto-Oncogene Proteins c-mycSIRT7 protein, humanSirt7 protein, mouseSirtuins

Identifiers

PMID24210820
PMCPMC3888240
OpenAlexW2146637989

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.